Charles Rudin
University of Chicago Comprehensive Cancer Center
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Project Leader
Ono Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Ido Wolf, MD
Tel-Aviv Sourasky Medical Center
Shared therapeutic areas:
Antony Magliocco, MD
Protean BioDiagnostics
Shared therapeutic areas:
Eugenie Younger, MD
Gloucestershire Hospitals NHS Foundation Trust
Shared therapeutic areas:
Andreas Polychronis, MD
Mount Vernon Cancer Centre
Shared therapeutic areas:
Adam Berger, MD
Rutgers Cancer Institute
Shared therapeutic areas:
Astrid Ammendola, MD
Asklepios Klinik Gauting GmbH
Shared therapeutic areas:
Igor Puzanov, MD
Roswell Park
Shared therapeutic areas:
Louise Medley, MD
Torbay and South Devon NHS foundation
Shared therapeutic areas:
Andrew Conn, MD
Bradford Teaching Hospitals
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
All 2 trials loaded